Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8485 |
Intermediate Similarity |
NPD8407 |
Phase 2 |
0.8415 |
Intermediate Similarity |
NPD8368 |
Discontinued |
0.8395 |
Intermediate Similarity |
NPD7799 |
Discontinued |
0.8344 |
Intermediate Similarity |
NPD7236 |
Approved |
0.8274 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.8194 |
Intermediate Similarity |
NPD7239 |
Suspended |
0.8176 |
Intermediate Similarity |
NPD8435 |
Approved |
0.807 |
Intermediate Similarity |
NPD8361 |
Approved |
0.807 |
Intermediate Similarity |
NPD8360 |
Approved |
0.7973 |
Intermediate Similarity |
NPD7966 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD8485 |
Approved |
0.7849 |
Intermediate Similarity |
NPD8424 |
Clinical (unspecified phase) |
0.7798 |
Intermediate Similarity |
NPD8470 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD8486 |
Clinical (unspecified phase) |
0.7746 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD7057 |
Phase 3 |
0.773 |
Intermediate Similarity |
NPD7058 |
Phase 2 |
0.767 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD5952 |
Clinical (unspecified phase) |
0.7607 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.758 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7576 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.755 |
Intermediate Similarity |
NPD7961 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7465 |
Intermediate Similarity |
NPD4198 |
Discontinued |
0.7407 |
Intermediate Similarity |
NPD8462 |
Phase 1 |
0.7394 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7368 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7349 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7321 |
Intermediate Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7267 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7246 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7219 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7219 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7193 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7186 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7186 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7174 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7174 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7167 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7166 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7165 |
Intermediate Similarity |
NPD8404 |
Phase 2 |
0.7159 |
Intermediate Similarity |
NPD6764 |
Approved |
0.7159 |
Intermediate Similarity |
NPD6765 |
Approved |
0.7143 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7135 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7117 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7117 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7113 |
Intermediate Similarity |
NPD2181 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7105 |
Intermediate Similarity |
NPD6007 |
Clinical (unspecified phase) |
0.7104 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7104 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7101 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7095 |
Intermediate Similarity |
NPD3412 |
Clinical (unspecified phase) |
0.7086 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7086 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7079 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7079 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7078 |
Intermediate Similarity |
NPD7008 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD7741 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7041 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7034 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.7031 |
Intermediate Similarity |
NPD7874 |
Approved |
0.703 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7029 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7024 |
Intermediate Similarity |
NPD37 |
Approved |
0.7022 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7012 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7011 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7011 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD6784 |
Approved |
0.7 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7 |
Intermediate Similarity |
NPD6785 |
Approved |
0.6994 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6982 |
Remote Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.6964 |
Remote Similarity |
NPD7411 |
Suspended |
0.6954 |
Remote Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.6928 |
Remote Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.6927 |
Remote Similarity |
NPD7808 |
Phase 3 |
0.6923 |
Remote Similarity |
NPD1934 |
Approved |
0.6918 |
Remote Similarity |
NPD5951 |
Approved |
0.6915 |
Remote Similarity |
NPD6778 |
Approved |
0.6915 |
Remote Similarity |
NPD6776 |
Approved |
0.6915 |
Remote Similarity |
NPD6777 |
Approved |
0.6915 |
Remote Similarity |
NPD6781 |
Approved |
0.6915 |
Remote Similarity |
NPD6780 |
Approved |
0.6915 |
Remote Similarity |
NPD6779 |
Approved |
0.6915 |
Remote Similarity |
NPD6782 |
Approved |
0.6914 |
Remote Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD8389 |
Clinical (unspecified phase) |
0.6909 |
Remote Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.6899 |
Remote Similarity |
NPD230 |
Phase 1 |
0.6899 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6895 |
Remote Similarity |
NPD7696 |
Phase 3 |
0.6895 |
Remote Similarity |
NPD7698 |
Approved |
0.6895 |
Remote Similarity |
NPD7697 |
Approved |
0.6895 |
Remote Similarity |
NPD7497 |
Discontinued |
0.6894 |
Remote Similarity |
NPD2346 |
Discontinued |
0.6894 |
Remote Similarity |
NPD7702 |
Clinical (unspecified phase) |
0.6882 |
Remote Similarity |
NPD2801 |
Approved |
0.6872 |
Remote Similarity |
NPD7685 |
Pre-registration |
0.6872 |
Remote Similarity |
NPD6559 |
Discontinued |
0.6872 |
Remote Similarity |
NPD7251 |
Discontinued |
0.6867 |
Remote Similarity |
NPD5126 |
Approved |
0.6867 |
Remote Similarity |
NPD6273 |
Approved |
0.6867 |
Remote Similarity |
NPD5125 |
Phase 3 |
0.686 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.686 |
Remote Similarity |
NPD3749 |
Approved |
0.6859 |
Remote Similarity |
NPD7870 |
Phase 2 |
0.6859 |
Remote Similarity |
NPD7871 |
Phase 2 |
0.6853 |
Remote Similarity |
NPD2182 |
Approved |
0.6839 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6836 |
Remote Similarity |
NPD7228 |
Approved |
0.6821 |
Remote Similarity |
NPD7457 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD919 |
Approved |
0.6821 |
Remote Similarity |
NPD7801 |
Approved |
0.6818 |
Remote Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.6816 |
Remote Similarity |
NPD6797 |
Phase 2 |
0.6807 |
Remote Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.6807 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6806 |
Remote Similarity |
NPD2067 |
Discontinued |
0.6802 |
Remote Similarity |
NPD7768 |
Phase 2 |
0.679 |
Remote Similarity |
NPD1471 |
Phase 3 |
0.6783 |
Remote Similarity |
NPD5345 |
Clinical (unspecified phase) |
0.6772 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.677 |
Remote Similarity |
NPD2799 |
Discontinued |
0.6768 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.676 |
Remote Similarity |
NPD7074 |
Phase 3 |
0.6752 |
Remote Similarity |
NPD7095 |
Approved |
0.6748 |
Remote Similarity |
NPD970 |
Clinical (unspecified phase) |
0.6747 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6746 |
Remote Similarity |
NPD6591 |
Clinical (unspecified phase) |
0.6743 |
Remote Similarity |
NPD6959 |
Discontinued |
0.6743 |
Remote Similarity |
NPD1247 |
Approved |
0.6743 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6736 |
Remote Similarity |
NPD6831 |
Clinical (unspecified phase) |
0.6728 |
Remote Similarity |
NPD2796 |
Approved |
0.6728 |
Remote Similarity |
NPD2935 |
Discontinued |
0.6727 |
Remote Similarity |
NPD7274 |
Clinical (unspecified phase) |
0.6712 |
Remote Similarity |
NPD1609 |
Clinical (unspecified phase) |
0.6709 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6709 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6707 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6707 |
Remote Similarity |
NPD2800 |
Approved |
0.6704 |
Remote Similarity |
NPD7054 |
Approved |
0.6687 |
Remote Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.6687 |
Remote Similarity |
NPD5762 |
Approved |
0.6687 |
Remote Similarity |
NPD3300 |
Phase 2 |
0.6687 |
Remote Similarity |
NPD5763 |
Approved |
0.6685 |
Remote Similarity |
NPD7240 |
Approved |
0.6683 |
Remote Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6287 |
Discontinued |
0.6667 |
Remote Similarity |
NPD6663 |
Approved |
0.6667 |
Remote Similarity |
NPD3926 |
Phase 2 |
0.6667 |
Remote Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD7094 |
Approved |
0.6667 |
Remote Similarity |
NPD7003 |
Approved |
0.6667 |
Remote Similarity |
NPD7472 |
Approved |
0.6667 |
Remote Similarity |
NPD1512 |
Approved |
0.6667 |
Remote Similarity |
NPD7305 |
Phase 1 |
0.6667 |
Remote Similarity |
NPD7610 |
Discontinued |
0.6667 |
Remote Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.6667 |
Remote Similarity |
NPD6858 |
Approved |
0.6667 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6649 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6646 |
Remote Similarity |
NPD1549 |
Phase 2 |
0.6645 |
Remote Similarity |
NPD7163 |
Clinical (unspecified phase) |
0.6644 |
Remote Similarity |
NPD4141 |
Clinical (unspecified phase) |
0.6633 |
Remote Similarity |
NPD8151 |
Discontinued |
0.6627 |
Remote Similarity |
NPD920 |
Approved |
0.6626 |
Remote Similarity |
NPD5406 |
Approved |
0.6626 |
Remote Similarity |
NPD6100 |
Approved |
0.6626 |
Remote Similarity |
NPD6099 |
Approved |
0.6626 |
Remote Similarity |
NPD5408 |
Approved |
0.6626 |
Remote Similarity |
NPD5404 |
Approved |
0.6626 |
Remote Similarity |
NPD5405 |
Approved |
0.6624 |
Remote Similarity |
NPD5736 |
Approved |
0.6623 |
Remote Similarity |
NPD6319 |
Approved |
0.6623 |
Remote Similarity |
NPD9545 |
Approved |
0.6622 |
Remote Similarity |
NPD6010 |
Discontinued |
0.661 |
Remote Similarity |
NPD5710 |
Approved |
0.661
|
Remote Similarity |
NPD5711 |
Approved |